tiprankstipranks
Trending News
More News >
Can-Fite BioPharma Ltd (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Income Statement

Compare
576 Followers

Can-Fite BioPharma Income Statement

Last quarter (Q4 2024), Can-Fite BioPharma's total revenue was $179.00K, an increase of 15.48% from the same quarter last year. In Q4, Can-Fite BioPharma's net income was $-1.96M. See Can-Fite BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Gross Profit
$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Operating Expenses
$ 8.80M$ 8.94M$ 10.91M$ 13.70M$ 14.90M
Depreciation and Amortization
$ 7.00K$ 15.00K$ 14.00K$ 14.00K$ 12.00K
EBITDA
$ -8.12M$ -8.18M$ -10.08M$ -12.83M$ -14.13M
Operating Income
$ -8.13M$ -8.20M$ -10.10M$ -12.84M$ -14.14M
Other Income/Expenses
$ 250.00K$ 561.00K$ -77.00K$ 227.00K$ -304.00K
Pretax Income
$ -7.88M$ -7.63M$ -10.17M$ -12.62M$ -14.44M
Net Income
$ -7.88M$ -7.63M$ -10.53M$ -12.60M$ -14.81M
Per Share Metrics
Basic EPS
$ -1.08$ -1.80$ -3.75$ -8.25$ -12.69
Diluted EPS
$ -1.08$ -1.80$ -3.75$ -8.25$ -12.69
Weighted Average Shares Outstanding
7.25M 4.26M 2.72M 1.53M 1.14M
Weighted Average Shares Outstanding (Diluted)
7.25M 4.26M 2.72M 1.84M 1.19M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis